Pulmonx Corporation announced the appointment of Mehul Joshi as Chief Financial Officer, effective April 3, 2024. He succeeds John McKune, who has served as the Company?s Interim Chief Financial Officer since October 10, 2023, and will transition to his prior role as Vice President, Corporate Controller. Mehul Joshi brings over 30 years of experience in finance, accounting and strategic planning having served in leadership roles across companies such as Gilead Sciences Inc., ResMed Inc., and most recently, as Chief Financial Officer of PhenomeX Inc., (formerly Berkeley Lights), prior to its acquisition by Bruker in 2023.

Prior to PhenomeX Inc., Mr. Joshi served in multiple senior finance roles of increasing responsibility at ResMed, including most recently, as Senior Vice President, Finance & Head of Global FP&A. During his eleven years at ResMed, Mr. Joshi played an integral role in reengineering the global finance teams to drive revenue growth and operating leverage. Prior to that, Mr. Joshi was Senior Director, Operations Finance at Gilead Sciences where he served across various roles for eight years. Mr. Joshi holds a Bachelor of Arts from Rutgers University and a Master of Business Administration from Rutgers Graduate School of Management.